Financial results for Q2 ended June 30, 2023
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 11860206
- Unconsolidated Pat
- -752393
- Unconsolidated Quarter Eps
- -2.36
- Unconsolidated Cumulative Eps
- -1.01